Search research articles
Contact Us
Filters
Showing results (211-220 of 220) with videos related to
Page
of 22
Sort By:
You have reached the last page of results.
This site can display upto 220 results.
Travel Medicine and Infectious Disease
|
December 6, 2019
Characteristics of Zika virus infection among international travelers: A prospective study from a Spanish referral unit
Clara Crespillo-Andújar, Marta Díaz-Menéndez, Elena Trigo, et al.
Viruses
|
February 28, 2023
Temporal Series Analysis of Population Cycle Threshold Counts as a Predictor of Surge in Cases and Hospitalizations during the SARS-CoV-2 Pandemic
Fernando Cava, Jesús San Román, Pablo Barreiro, et al.
The Journal of Infectious Diseases
|
July 19, 2012
Comparison of high ribavirin induction versus standard ribavirin dosing, plus peginterferon-α for the treatment of chronic hepatitis C in HIV-infected patients: the PERICO trial
Pablo Labarga, Pablo Barreiro, Alfredo da Silva, et al.
AIDS Research and Human Retroviruses
|
August 30, 2007
Role of weight-based ribavirin dosing and extended duration of therapy in chronic hepatitis C in HIV-infected patients: the PRESCO trial
Marina Núñez, Celia Miralles, Miguel Angel Berdún, et al.
Vaccines
|
March 26, 2022
Humoral and Cellular Response after mRNA Vaccination in Nursing Homes: Influence of Age and of History of COVID-19
Jesús San Román, Francisco Javier Candel, Juan Carlos Sanz, et al.
AIDS (London, England)
|
July 13, 2017
Human T-lymphotropic virus type 1 infection and disease in Spain
Carmen de Mendoza, Estrella Caballero, Antonio Aguilera, et al.
Antiviral Therapy
|
August 3, 2007
Premature treatment discontinuation in HIV/HCV-coinfected patients receiving pegylated interferon plus weight-based ribavirin
Vincent Soriano, Celia Miralles, Miguel Angel Berdún, et al.
The Journal of Antimicrobial Chemotherapy
|
October 16, 2008
Efficacy of pegylated interferon plus ribavirin treatment in HIV/hepatitis C virus co-infected patients receiving abacavir plus lamivudine or tenofovir plus either lamivudine or emtricitabine as nucleoside analogue backbone
José A Mira, Luis F López-Cortés, Pablo Barreiro, et al.
Viruses
|
July 29, 2023
Expert Consensus: Main Risk Factors for Poor Prognosis in COVID-19 and the Implications for Targeted Measures against SARS-CoV-2
Francisco Javier Candel, Pablo Barreiro, Miguel Salavert, et al.
Open Forum Infectious Diseases
|
September 22, 2020
Development of a Standardized Data Collection Tool for Evaluation and Management of Coronavirus Disease 2019
Stephen R Morris, Yoichiro Natori, Douglas Salguero, et al.
Page
of 22
Search research articles
Search
Showing results (211-220 of 220) with videos related to
Sort By:
Page
of 22
You have reached the last page of results.
This site can display upto 220 results.
Travel Medicine and Infectious Disease
|
December 6, 2019
Characteristics of Zika virus infection among international travelers: A prospective study from a Spanish referral unit
Clara Crespillo-Andújar, Marta Díaz-Menéndez, Elena Trigo, et al.
Viruses
|
February 28, 2023
Temporal Series Analysis of Population Cycle Threshold Counts as a Predictor of Surge in Cases and Hospitalizations during the SARS-CoV-2 Pandemic
Fernando Cava, Jesús San Román, Pablo Barreiro, et al.
The Journal of Infectious Diseases
|
July 19, 2012
Comparison of high ribavirin induction versus standard ribavirin dosing, plus peginterferon-α for the treatment of chronic hepatitis C in HIV-infected patients: the PERICO trial
Pablo Labarga, Pablo Barreiro, Alfredo da Silva, et al.
AIDS Research and Human Retroviruses
|
August 30, 2007
Role of weight-based ribavirin dosing and extended duration of therapy in chronic hepatitis C in HIV-infected patients: the PRESCO trial
Marina Núñez, Celia Miralles, Miguel Angel Berdún, et al.
Vaccines
|
March 26, 2022
Humoral and Cellular Response after mRNA Vaccination in Nursing Homes: Influence of Age and of History of COVID-19
Jesús San Román, Francisco Javier Candel, Juan Carlos Sanz, et al.
AIDS (London, England)
|
July 13, 2017
Human T-lymphotropic virus type 1 infection and disease in Spain
Carmen de Mendoza, Estrella Caballero, Antonio Aguilera, et al.
Antiviral Therapy
|
August 3, 2007
Premature treatment discontinuation in HIV/HCV-coinfected patients receiving pegylated interferon plus weight-based ribavirin
Vincent Soriano, Celia Miralles, Miguel Angel Berdún, et al.
The Journal of Antimicrobial Chemotherapy
|
October 16, 2008
Efficacy of pegylated interferon plus ribavirin treatment in HIV/hepatitis C virus co-infected patients receiving abacavir plus lamivudine or tenofovir plus either lamivudine or emtricitabine as nucleoside analogue backbone
José A Mira, Luis F López-Cortés, Pablo Barreiro, et al.
Viruses
|
July 29, 2023
Expert Consensus: Main Risk Factors for Poor Prognosis in COVID-19 and the Implications for Targeted Measures against SARS-CoV-2
Francisco Javier Candel, Pablo Barreiro, Miguel Salavert, et al.
Open Forum Infectious Diseases
|
September 22, 2020
Development of a Standardized Data Collection Tool for Evaluation and Management of Coronavirus Disease 2019
Stephen R Morris, Yoichiro Natori, Douglas Salguero, et al.
Page
of 22